Finacea (Intendis Inc.)
Welcome to the PulseAid listing for the Finacea drug offered from Intendis Inc.. This Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Intendis Inc. |
NON-PROPRIETARY NAME: | azelaic acid |
SUBSTANCE NAME: | AZELAIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-12-24 |
END MARKETING DATE: | 0000-00-00 |
Finacea HUMAN PRESCRIPTION DRUG Details:
Item Description | Finacea from Intendis Inc. |
LABELER NAME: | Intendis Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.15(g/g) |
START MARKETING DATE: | 2004-12-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10922-825_a7594a20-f46e-4b33-91d5-410cc5e97b8d |
PRODUCT NDC: | 10922-825 |
APPLICATION NUMBER: | NDA021470 |
Other AZELAIC ACID Pharmaceutical Manufacturers / Labelers: